nodes	percent_of_prediction	percent_of_DWPC	metapath
Succinylcholine—BCHE—Triamcinolone—hematologic cancer	0.0769	0.421	CbGbCtD
Succinylcholine—BCHE—Irinotecan—hematologic cancer	0.0583	0.319	CbGbCtD
Succinylcholine—BCHE—Cisplatin—hematologic cancer	0.0475	0.26	CbGbCtD
Succinylcholine—CHRNE—blood—hematologic cancer	0.0212	0.138	CbGeAlD
Succinylcholine—CHRNE—testis—hematologic cancer	0.0175	0.114	CbGeAlD
Succinylcholine—CHRNA10—hematopoietic system—hematologic cancer	0.0135	0.0882	CbGeAlD
Succinylcholine—CHRNG—blood—hematologic cancer	0.0106	0.0689	CbGeAlD
Succinylcholine—CHRNA1—hematopoietic system—hematologic cancer	0.0106	0.0688	CbGeAlD
Succinylcholine—CHRNG—bone marrow—hematologic cancer	0.0102	0.0667	CbGeAlD
Succinylcholine—CHRNG—lung—hematologic cancer	0.00927	0.0604	CbGeAlD
Succinylcholine—CHRNA10—blood—hematologic cancer	0.00897	0.0584	CbGeAlD
Succinylcholine—CHRNA10—testis—hematologic cancer	0.00742	0.0483	CbGeAlD
Succinylcholine—CHRND—lung—hematologic cancer	0.00735	0.0479	CbGeAlD
Succinylcholine—CHRNB1—blood—hematologic cancer	0.00541	0.0352	CbGeAlD
Succinylcholine—CHRNA10—lymph node—hematologic cancer	0.00538	0.035	CbGeAlD
Succinylcholine—CHRNB1—testis—hematologic cancer	0.00447	0.0291	CbGeAlD
Succinylcholine—BCHE—hematopoietic system—hematologic cancer	0.00348	0.0227	CbGeAlD
Succinylcholine—CHRNB1—lymph node—hematologic cancer	0.00324	0.0211	CbGeAlD
Succinylcholine—CHRM1—lung—hematologic cancer	0.00276	0.018	CbGeAlD
Succinylcholine—CHRM3—testis—hematologic cancer	0.00233	0.0152	CbGeAlD
Succinylcholine—BCHE—blood—hematologic cancer	0.0023	0.015	CbGeAlD
Succinylcholine—BCHE—bone marrow—hematologic cancer	0.00223	0.0145	CbGeAlD
Succinylcholine—BCHE—lung—hematologic cancer	0.00202	0.0132	CbGeAlD
Succinylcholine—BCHE—testis—hematologic cancer	0.00191	0.0124	CbGeAlD
Succinylcholine—BCHE—lymph node—hematologic cancer	0.00138	0.009	CbGeAlD
Succinylcholine—Tachycardia—Thalidomide—hematologic cancer	0.000535	0.00105	CcSEcCtD
Succinylcholine—Flushing—Etoposide—hematologic cancer	0.000532	0.00105	CcSEcCtD
Succinylcholine—Hypertension—Vincristine—hematologic cancer	0.000531	0.00105	CcSEcCtD
Succinylcholine—Rash—Procarbazine—hematologic cancer	0.00053	0.00105	CcSEcCtD
Succinylcholine—Dermatitis—Procarbazine—hematologic cancer	0.00053	0.00104	CcSEcCtD
Succinylcholine—Bradycardia—Triamcinolone—hematologic cancer	0.000529	0.00104	CcSEcCtD
Succinylcholine—Pulmonary oedema—Doxorubicin—hematologic cancer	0.000527	0.00104	CcSEcCtD
Succinylcholine—Hypersensitivity—Vinblastine—hematologic cancer	0.000526	0.00104	CcSEcCtD
Succinylcholine—Urticaria—Lenalidomide—hematologic cancer	0.000525	0.00103	CcSEcCtD
Succinylcholine—Myalgia—Vincristine—hematologic cancer	0.000524	0.00103	CcSEcCtD
Succinylcholine—Body temperature increased—Lenalidomide—hematologic cancer	0.000522	0.00103	CcSEcCtD
Succinylcholine—Anaphylactic shock—Alitretinoin—hematologic cancer	0.000521	0.00103	CcSEcCtD
Succinylcholine—Rash—Dasatinib—hematologic cancer	0.00052	0.00102	CcSEcCtD
Succinylcholine—Rash—Bexarotene—hematologic cancer	0.00052	0.00102	CcSEcCtD
Succinylcholine—Dermatitis—Bexarotene—hematologic cancer	0.000519	0.00102	CcSEcCtD
Succinylcholine—Dermatitis—Dasatinib—hematologic cancer	0.000519	0.00102	CcSEcCtD
Succinylcholine—Hypertonia—Doxorubicin—hematologic cancer	0.000519	0.00102	CcSEcCtD
Succinylcholine—Rash—Fludarabine—hematologic cancer	0.000519	0.00102	CcSEcCtD
Succinylcholine—Dermatitis—Fludarabine—hematologic cancer	0.000518	0.00102	CcSEcCtD
Succinylcholine—Hypertension—Irinotecan—hematologic cancer	0.000518	0.00102	CcSEcCtD
Succinylcholine—Hypertension—Mitoxantrone—hematologic cancer	0.000518	0.00102	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Thiotepa—hematologic cancer	0.000516	0.00102	CcSEcCtD
Succinylcholine—Anaphylactic shock—Ifosfamide—hematologic cancer	0.000515	0.00102	CcSEcCtD
Succinylcholine—Body temperature increased—Hydroxyurea—hematologic cancer	0.000515	0.00101	CcSEcCtD
Succinylcholine—Tachycardia—Carmustine—hematologic cancer	0.000514	0.00101	CcSEcCtD
Succinylcholine—Shock—Alitretinoin—hematologic cancer	0.000513	0.00101	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Methotrexate—hematologic cancer	0.000512	0.00101	CcSEcCtD
Succinylcholine—Hypotension—Thalidomide—hematologic cancer	0.000512	0.00101	CcSEcCtD
Succinylcholine—Myalgia—Mitoxantrone—hematologic cancer	0.00051	0.00101	CcSEcCtD
Succinylcholine—Tachycardia—Alitretinoin—hematologic cancer	0.000509	0.001	CcSEcCtD
Succinylcholine—Arrhythmia—Prednisolone—hematologic cancer	0.000505	0.000994	CcSEcCtD
Succinylcholine—Hypertension—Gemcitabine—hematologic cancer	0.000504	0.000993	CcSEcCtD
Succinylcholine—Renal failure acute—Epirubicin—hematologic cancer	0.000503	0.000991	CcSEcCtD
Succinylcholine—Anaphylactic shock—Vincristine—hematologic cancer	0.000502	0.00099	CcSEcCtD
Succinylcholine—Hypersensitivity—Melphalan—hematologic cancer	0.0005	0.000986	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Thalidomide—hematologic cancer	0.000499	0.000984	CcSEcCtD
Succinylcholine—Myalgia—Gemcitabine—hematologic cancer	0.000497	0.00098	CcSEcCtD
Succinylcholine—Hypotension—Carmustine—hematologic cancer	0.000492	0.000969	CcSEcCtD
Succinylcholine—Anaphylactic shock—Irinotecan—hematologic cancer	0.000489	0.000964	CcSEcCtD
Succinylcholine—Anaphylactic shock—Mitoxantrone—hematologic cancer	0.000489	0.000964	CcSEcCtD
Succinylcholine—Hypotension—Alitretinoin—hematologic cancer	0.000487	0.00096	CcSEcCtD
Succinylcholine—Hypersensitivity—Lenalidomide—hematologic cancer	0.000486	0.000958	CcSEcCtD
Succinylcholine—Urticaria—Bortezomib—hematologic cancer	0.000483	0.000951	CcSEcCtD
Succinylcholine—Hypotension—Ifosfamide—hematologic cancer	0.000482	0.000949	CcSEcCtD
Succinylcholine—Shock—Mitoxantrone—hematologic cancer	0.000481	0.000948	CcSEcCtD
Succinylcholine—Shock—Irinotecan—hematologic cancer	0.000481	0.000948	CcSEcCtD
Succinylcholine—Rash—Nilotinib—hematologic cancer	0.00048	0.000946	CcSEcCtD
Succinylcholine—Body temperature increased—Bortezomib—hematologic cancer	0.00048	0.000946	CcSEcCtD
Succinylcholine—Bradycardia—Betamethasone—hematologic cancer	0.00048	0.000946	CcSEcCtD
Succinylcholine—Bradycardia—Dexamethasone—hematologic cancer	0.00048	0.000946	CcSEcCtD
Succinylcholine—Dermatitis—Nilotinib—hematologic cancer	0.00048	0.000946	CcSEcCtD
Succinylcholine—Hypersensitivity—Hydroxyurea—hematologic cancer	0.00048	0.000945	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Epirubicin—hematologic cancer	0.00048	0.000945	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Carmustine—hematologic cancer	0.00048	0.000945	CcSEcCtD
Succinylcholine—Urticaria—Bleomycin—hematologic cancer	0.000479	0.000944	CcSEcCtD
Succinylcholine—Rash—Imatinib—hematologic cancer	0.000478	0.000941	CcSEcCtD
Succinylcholine—Tachycardia—Mitoxantrone—hematologic cancer	0.000478	0.000941	CcSEcCtD
Succinylcholine—Dermatitis—Imatinib—hematologic cancer	0.000477	0.00094	CcSEcCtD
Succinylcholine—Body temperature increased—Bleomycin—hematologic cancer	0.000477	0.000939	CcSEcCtD
Succinylcholine—Anaphylactic shock—Gemcitabine—hematologic cancer	0.000477	0.000939	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Alitretinoin—hematologic cancer	0.000475	0.000936	CcSEcCtD
Succinylcholine—Urticaria—Vinorelbine—hematologic cancer	0.000471	0.000929	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Ifosfamide—hematologic cancer	0.000469	0.000925	CcSEcCtD
Succinylcholine—Hypotension—Vincristine—hematologic cancer	0.000469	0.000925	CcSEcCtD
Succinylcholine—Rash—Cladribine—hematologic cancer	0.000469	0.000925	CcSEcCtD
Succinylcholine—Body temperature increased—Vinorelbine—hematologic cancer	0.000469	0.000924	CcSEcCtD
Succinylcholine—Dermatitis—Cladribine—hematologic cancer	0.000469	0.000924	CcSEcCtD
Succinylcholine—Renal failure acute—Doxorubicin—hematologic cancer	0.000465	0.000917	CcSEcCtD
Succinylcholine—Arrhythmia—Triamcinolone—hematologic cancer	0.000464	0.000915	CcSEcCtD
Succinylcholine—Myalgia—Cisplatin—hematologic cancer	0.000463	0.000913	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Vincristine—hematologic cancer	0.000458	0.000902	CcSEcCtD
Succinylcholine—Hypotension—Irinotecan—hematologic cancer	0.000457	0.000901	CcSEcCtD
Succinylcholine—Hypotension—Mitoxantrone—hematologic cancer	0.000457	0.000901	CcSEcCtD
Succinylcholine—Urticaria—Thiotepa—hematologic cancer	0.00045	0.000887	CcSEcCtD
Succinylcholine—Body temperature increased—Thiotepa—hematologic cancer	0.000448	0.000882	CcSEcCtD
Succinylcholine—Hypersensitivity—Bortezomib—hematologic cancer	0.000448	0.000882	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Mitoxantrone—hematologic cancer	0.000446	0.000878	CcSEcCtD
Succinylcholine—Hypotension—Gemcitabine—hematologic cancer	0.000445	0.000877	CcSEcCtD
Succinylcholine—Anaphylactic shock—Cisplatin—hematologic cancer	0.000444	0.000875	CcSEcCtD
Succinylcholine—Hypersensitivity—Bleomycin—hematologic cancer	0.000444	0.000875	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Doxorubicin—hematologic cancer	0.000444	0.000874	CcSEcCtD
Succinylcholine—Cardiac arrest—Epirubicin—hematologic cancer	0.000441	0.00087	CcSEcCtD
Succinylcholine—Hypersensitivity—Vinorelbine—hematologic cancer	0.000437	0.000861	CcSEcCtD
Succinylcholine—Urticaria—Thalidomide—hematologic cancer	0.000435	0.000858	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Gemcitabine—hematologic cancer	0.000434	0.000856	CcSEcCtD
Succinylcholine—Tachycardia—Cisplatin—hematologic cancer	0.000434	0.000854	CcSEcCtD
Succinylcholine—Body temperature increased—Thalidomide—hematologic cancer	0.000433	0.000854	CcSEcCtD
Succinylcholine—Hypertension—Etoposide—hematologic cancer	0.000431	0.000848	CcSEcCtD
Succinylcholine—Rash—Melphalan—hematologic cancer	0.000428	0.000844	CcSEcCtD
Succinylcholine—Dermatitis—Melphalan—hematologic cancer	0.000428	0.000843	CcSEcCtD
Succinylcholine—Hypertension—Prednisolone—hematologic cancer	0.000425	0.000837	CcSEcCtD
Succinylcholine—Arrhythmia—Betamethasone—hematologic cancer	0.000421	0.00083	CcSEcCtD
Succinylcholine—Arrhythmia—Dexamethasone—hematologic cancer	0.000421	0.00083	CcSEcCtD
Succinylcholine—Bradycardia—Prednisone—hematologic cancer	0.000418	0.000824	CcSEcCtD
Succinylcholine—Hypersensitivity—Thiotepa—hematologic cancer	0.000417	0.000822	CcSEcCtD
Succinylcholine—Rash—Lenalidomide—hematologic cancer	0.000416	0.00082	CcSEcCtD
Succinylcholine—Body temperature increased—Carmustine—hematologic cancer	0.000416	0.00082	CcSEcCtD
Succinylcholine—Dermatitis—Lenalidomide—hematologic cancer	0.000416	0.00082	CcSEcCtD
Succinylcholine—Hypotension—Cisplatin—hematologic cancer	0.000415	0.000818	CcSEcCtD
Succinylcholine—Urticaria—Alitretinoin—hematologic cancer	0.000414	0.000816	CcSEcCtD
Succinylcholine—Body temperature increased—Alitretinoin—hematologic cancer	0.000412	0.000812	CcSEcCtD
Succinylcholine—Rash—Hydroxyurea—hematologic cancer	0.000411	0.000809	CcSEcCtD
Succinylcholine—Dermatitis—Hydroxyurea—hematologic cancer	0.00041	0.000808	CcSEcCtD
Succinylcholine—Urticaria—Ifosfamide—hematologic cancer	0.000409	0.000807	CcSEcCtD
Succinylcholine—Cardiac arrest—Doxorubicin—hematologic cancer	0.000408	0.000805	CcSEcCtD
Succinylcholine—Body temperature increased—Ifosfamide—hematologic cancer	0.000407	0.000803	CcSEcCtD
Succinylcholine—Anaphylactic shock—Etoposide—hematologic cancer	0.000407	0.000802	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Cisplatin—hematologic cancer	0.000405	0.000797	CcSEcCtD
Succinylcholine—Hypersensitivity—Thalidomide—hematologic cancer	0.000404	0.000795	CcSEcCtD
Succinylcholine—Anaphylactic shock—Prednisolone—hematologic cancer	0.000401	0.000791	CcSEcCtD
Succinylcholine—Tachycardia—Etoposide—hematologic cancer	0.000397	0.000783	CcSEcCtD
Succinylcholine—Body temperature increased—Vincristine—hematologic cancer	0.000397	0.000783	CcSEcCtD
Succinylcholine—Shock—Prednisolone—hematologic cancer	0.000395	0.000778	CcSEcCtD
Succinylcholine—Tachycardia—Prednisolone—hematologic cancer	0.000392	0.000772	CcSEcCtD
Succinylcholine—Hypertension—Triamcinolone—hematologic cancer	0.000391	0.000769	CcSEcCtD
Succinylcholine—Urticaria—Mitoxantrone—hematologic cancer	0.000389	0.000766	CcSEcCtD
Succinylcholine—Hypersensitivity—Carmustine—hematologic cancer	0.000388	0.000764	CcSEcCtD
Succinylcholine—Body temperature increased—Irinotecan—hematologic cancer	0.000387	0.000762	CcSEcCtD
Succinylcholine—Body temperature increased—Mitoxantrone—hematologic cancer	0.000387	0.000762	CcSEcCtD
Succinylcholine—Myalgia—Triamcinolone—hematologic cancer	0.000385	0.000759	CcSEcCtD
Succinylcholine—Hypersensitivity—Alitretinoin—hematologic cancer	0.000384	0.000757	CcSEcCtD
Succinylcholine—Rash—Bortezomib—hematologic cancer	0.000383	0.000755	CcSEcCtD
Succinylcholine—Dermatitis—Bortezomib—hematologic cancer	0.000383	0.000754	CcSEcCtD
Succinylcholine—Flushing—Prednisone—hematologic cancer	0.000381	0.000751	CcSEcCtD
Succinylcholine—Hypotension—Etoposide—hematologic cancer	0.00038	0.000749	CcSEcCtD
Succinylcholine—Rash—Bleomycin—hematologic cancer	0.00038	0.000749	CcSEcCtD
Succinylcholine—Dermatitis—Bleomycin—hematologic cancer	0.00038	0.000748	CcSEcCtD
Succinylcholine—Hypersensitivity—Ifosfamide—hematologic cancer	0.00038	0.000748	CcSEcCtD
Succinylcholine—Body temperature increased—Gemcitabine—hematologic cancer	0.000377	0.000742	CcSEcCtD
Succinylcholine—Renal failure—Methotrexate—hematologic cancer	0.000376	0.00074	CcSEcCtD
Succinylcholine—Rash—Vinorelbine—hematologic cancer	0.000374	0.000737	CcSEcCtD
Succinylcholine—Dermatitis—Vinorelbine—hematologic cancer	0.000374	0.000736	CcSEcCtD
Succinylcholine—Hypersensitivity—Vincristine—hematologic cancer	0.00037	0.000729	CcSEcCtD
Succinylcholine—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000369	0.000727	CcSEcCtD
Succinylcholine—Arrhythmia—Prednisone—hematologic cancer	0.000367	0.000723	CcSEcCtD
Succinylcholine—Shock—Triamcinolone—hematologic cancer	0.000363	0.000716	CcSEcCtD
Succinylcholine—Hypersensitivity—Mitoxantrone—hematologic cancer	0.00036	0.00071	CcSEcCtD
Succinylcholine—Hypersensitivity—Irinotecan—hematologic cancer	0.00036	0.00071	CcSEcCtD
Succinylcholine—Tachycardia—Triamcinolone—hematologic cancer	0.00036	0.00071	CcSEcCtD
Succinylcholine—Rash—Thiotepa—hematologic cancer	0.000357	0.000704	CcSEcCtD
Succinylcholine—Dermatitis—Thiotepa—hematologic cancer	0.000357	0.000703	CcSEcCtD
Succinylcholine—Hypertension—Betamethasone—hematologic cancer	0.000354	0.000698	CcSEcCtD
Succinylcholine—Hypertension—Dexamethasone—hematologic cancer	0.000354	0.000698	CcSEcCtD
Succinylcholine—Renal failure—Epirubicin—hematologic cancer	0.000352	0.000693	CcSEcCtD
Succinylcholine—Body temperature increased—Cisplatin—hematologic cancer	0.000351	0.000692	CcSEcCtD
Succinylcholine—Myalgia—Betamethasone—hematologic cancer	0.000349	0.000688	CcSEcCtD
Succinylcholine—Myalgia—Dexamethasone—hematologic cancer	0.000349	0.000688	CcSEcCtD
Succinylcholine—Rash—Thalidomide—hematologic cancer	0.000346	0.000681	CcSEcCtD
Succinylcholine—Dermatitis—Thalidomide—hematologic cancer	0.000345	0.00068	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	0.000336	0.000663	CcSEcCtD
Succinylcholine—Anaphylactic shock—Betamethasone—hematologic cancer	0.000335	0.00066	CcSEcCtD
Succinylcholine—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000335	0.00066	CcSEcCtD
Succinylcholine—Rash—Carmustine—hematologic cancer	0.000332	0.000654	CcSEcCtD
Succinylcholine—Dermatitis—Carmustine—hematologic cancer	0.000332	0.000653	CcSEcCtD
Succinylcholine—Shock—Betamethasone—hematologic cancer	0.00033	0.000649	CcSEcCtD
Succinylcholine—Shock—Dexamethasone—hematologic cancer	0.00033	0.000649	CcSEcCtD
Succinylcholine—Rash—Alitretinoin—hematologic cancer	0.000329	0.000648	CcSEcCtD
Succinylcholine—Dermatitis—Alitretinoin—hematologic cancer	0.000328	0.000647	CcSEcCtD
Succinylcholine—Hypersensitivity—Cisplatin—hematologic cancer	0.000327	0.000645	CcSEcCtD
Succinylcholine—Tachycardia—Dexamethasone—hematologic cancer	0.000327	0.000644	CcSEcCtD
Succinylcholine—Tachycardia—Betamethasone—hematologic cancer	0.000327	0.000644	CcSEcCtD
Succinylcholine—Bradycardia—Epirubicin—hematologic cancer	0.000327	0.000644	CcSEcCtD
Succinylcholine—Renal failure—Doxorubicin—hematologic cancer	0.000325	0.000641	CcSEcCtD
Succinylcholine—Rash—Ifosfamide—hematologic cancer	0.000325	0.00064	CcSEcCtD
Succinylcholine—Dermatitis—Ifosfamide—hematologic cancer	0.000325	0.00064	CcSEcCtD
Succinylcholine—Urticaria—Etoposide—hematologic cancer	0.000323	0.000637	CcSEcCtD
Succinylcholine—Body temperature increased—Etoposide—hematologic cancer	0.000322	0.000634	CcSEcCtD
Succinylcholine—Urticaria—Prednisolone—hematologic cancer	0.000319	0.000628	CcSEcCtD
Succinylcholine—Rash—Vincristine—hematologic cancer	0.000317	0.000624	CcSEcCtD
Succinylcholine—Dermatitis—Vincristine—hematologic cancer	0.000316	0.000624	CcSEcCtD
Succinylcholine—Hypotension—Betamethasone—hematologic cancer	0.000313	0.000617	CcSEcCtD
Succinylcholine—Hypotension—Dexamethasone—hematologic cancer	0.000313	0.000617	CcSEcCtD
Succinylcholine—Hypertension—Prednisone—hematologic cancer	0.000309	0.000608	CcSEcCtD
Succinylcholine—Rash—Mitoxantrone—hematologic cancer	0.000309	0.000608	CcSEcCtD
Succinylcholine—Rash—Irinotecan—hematologic cancer	0.000309	0.000608	CcSEcCtD
Succinylcholine—Dermatitis—Irinotecan—hematologic cancer	0.000308	0.000607	CcSEcCtD
Succinylcholine—Dermatitis—Mitoxantrone—hematologic cancer	0.000308	0.000607	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	0.000305	0.000601	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	0.000305	0.000601	CcSEcCtD
Succinylcholine—Myalgia—Prednisone—hematologic cancer	0.000304	0.0006	CcSEcCtD
Succinylcholine—Bradycardia—Doxorubicin—hematologic cancer	0.000302	0.000596	CcSEcCtD
Succinylcholine—Rash—Gemcitabine—hematologic cancer	0.000301	0.000592	CcSEcCtD
Succinylcholine—Dermatitis—Gemcitabine—hematologic cancer	0.0003	0.000592	CcSEcCtD
Succinylcholine—Hypersensitivity—Etoposide—hematologic cancer	0.0003	0.000591	CcSEcCtD
Succinylcholine—Flushing—Epirubicin—hematologic cancer	0.000298	0.000587	CcSEcCtD
Succinylcholine—Hypersensitivity—Prednisolone—hematologic cancer	0.000296	0.000583	CcSEcCtD
Succinylcholine—Urticaria—Triamcinolone—hematologic cancer	0.000293	0.000578	CcSEcCtD
Succinylcholine—Body temperature increased—Triamcinolone—hematologic cancer	0.000292	0.000575	CcSEcCtD
Succinylcholine—Anaphylactic shock—Prednisone—hematologic cancer	0.000292	0.000575	CcSEcCtD
Succinylcholine—Shock—Prednisone—hematologic cancer	0.000287	0.000565	CcSEcCtD
Succinylcholine—Arrhythmia—Epirubicin—hematologic cancer	0.000287	0.000565	CcSEcCtD
Succinylcholine—Tachycardia—Prednisone—hematologic cancer	0.000285	0.000561	CcSEcCtD
Succinylcholine—Rash—Cisplatin—hematologic cancer	0.00028	0.000552	CcSEcCtD
Succinylcholine—Dermatitis—Cisplatin—hematologic cancer	0.00028	0.000551	CcSEcCtD
Succinylcholine—Flushing—Doxorubicin—hematologic cancer	0.000276	0.000543	CcSEcCtD
Succinylcholine—Hypersensitivity—Triamcinolone—hematologic cancer	0.000272	0.000536	CcSEcCtD
Succinylcholine—Urticaria—Betamethasone—hematologic cancer	0.000266	0.000524	CcSEcCtD
Succinylcholine—Urticaria—Dexamethasone—hematologic cancer	0.000266	0.000524	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Prednisone—hematologic cancer	0.000266	0.000524	CcSEcCtD
Succinylcholine—Arrhythmia—Doxorubicin—hematologic cancer	0.000265	0.000523	CcSEcCtD
Succinylcholine—Body temperature increased—Dexamethasone—hematologic cancer	0.000265	0.000522	CcSEcCtD
Succinylcholine—Body temperature increased—Betamethasone—hematologic cancer	0.000265	0.000522	CcSEcCtD
Succinylcholine—Rash—Etoposide—hematologic cancer	0.000257	0.000506	CcSEcCtD
Succinylcholine—Dermatitis—Etoposide—hematologic cancer	0.000256	0.000505	CcSEcCtD
Succinylcholine—Myalgia—Methotrexate—hematologic cancer	0.000254	0.000501	CcSEcCtD
Succinylcholine—Rash—Prednisolone—hematologic cancer	0.000253	0.000499	CcSEcCtD
Succinylcholine—Dermatitis—Prednisolone—hematologic cancer	0.000253	0.000498	CcSEcCtD
Succinylcholine—Anaphylactic shock—Methotrexate—hematologic cancer	0.000244	0.00048	CcSEcCtD
Succinylcholine—Hypertension—Epirubicin—hematologic cancer	0.000241	0.000476	CcSEcCtD
Succinylcholine—Myalgia—Epirubicin—hematologic cancer	0.000238	0.000469	CcSEcCtD
Succinylcholine—Rash—Triamcinolone—hematologic cancer	0.000233	0.000459	CcSEcCtD
Succinylcholine—Dermatitis—Triamcinolone—hematologic cancer	0.000233	0.000458	CcSEcCtD
Succinylcholine—Urticaria—Prednisone—hematologic cancer	0.000232	0.000457	CcSEcCtD
Succinylcholine—Body temperature increased—Prednisone—hematologic cancer	0.000231	0.000454	CcSEcCtD
Succinylcholine—Anaphylactic shock—Epirubicin—hematologic cancer	0.000228	0.000449	CcSEcCtD
Succinylcholine—Hypotension—Methotrexate—hematologic cancer	0.000228	0.000449	CcSEcCtD
Succinylcholine—Shock—Epirubicin—hematologic cancer	0.000224	0.000442	CcSEcCtD
Succinylcholine—Hypertension—Doxorubicin—hematologic cancer	0.000223	0.00044	CcSEcCtD
Succinylcholine—Tachycardia—Epirubicin—hematologic cancer	0.000223	0.000439	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	0.000222	0.000438	CcSEcCtD
Succinylcholine—Myalgia—Doxorubicin—hematologic cancer	0.00022	0.000434	CcSEcCtD
Succinylcholine—Hypersensitivity—Prednisone—hematologic cancer	0.000215	0.000423	CcSEcCtD
Succinylcholine—Hypotension—Epirubicin—hematologic cancer	0.000213	0.00042	CcSEcCtD
Succinylcholine—Rash—Dexamethasone—hematologic cancer	0.000211	0.000416	CcSEcCtD
Succinylcholine—Rash—Betamethasone—hematologic cancer	0.000211	0.000416	CcSEcCtD
Succinylcholine—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000211	0.000416	CcSEcCtD
Succinylcholine—Dermatitis—Betamethasone—hematologic cancer	0.000211	0.000416	CcSEcCtD
Succinylcholine—Dermatitis—Dexamethasone—hematologic cancer	0.000211	0.000416	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	0.000208	0.00041	CcSEcCtD
Succinylcholine—Shock—Doxorubicin—hematologic cancer	0.000208	0.000409	CcSEcCtD
Succinylcholine—Tachycardia—Doxorubicin—hematologic cancer	0.000206	0.000406	CcSEcCtD
Succinylcholine—Hypotension—Doxorubicin—hematologic cancer	0.000197	0.000389	CcSEcCtD
Succinylcholine—Urticaria—Methotrexate—hematologic cancer	0.000194	0.000382	CcSEcCtD
Succinylcholine—Body temperature increased—Methotrexate—hematologic cancer	0.000193	0.00038	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	0.000192	0.000379	CcSEcCtD
Succinylcholine—Rash—Prednisone—hematologic cancer	0.000184	0.000362	CcSEcCtD
Succinylcholine—Dermatitis—Prednisone—hematologic cancer	0.000184	0.000362	CcSEcCtD
Succinylcholine—Urticaria—Epirubicin—hematologic cancer	0.000181	0.000357	CcSEcCtD
Succinylcholine—Body temperature increased—Epirubicin—hematologic cancer	0.00018	0.000355	CcSEcCtD
Succinylcholine—Hypersensitivity—Methotrexate—hematologic cancer	0.00018	0.000354	CcSEcCtD
Succinylcholine—Hypersensitivity—Epirubicin—hematologic cancer	0.000168	0.000331	CcSEcCtD
Succinylcholine—Urticaria—Doxorubicin—hematologic cancer	0.000168	0.00033	CcSEcCtD
Succinylcholine—Body temperature increased—Doxorubicin—hematologic cancer	0.000167	0.000329	CcSEcCtD
Succinylcholine—Hypersensitivity—Doxorubicin—hematologic cancer	0.000156	0.000306	CcSEcCtD
Succinylcholine—Rash—Methotrexate—hematologic cancer	0.000154	0.000303	CcSEcCtD
Succinylcholine—Dermatitis—Methotrexate—hematologic cancer	0.000154	0.000303	CcSEcCtD
Succinylcholine—Rash—Epirubicin—hematologic cancer	0.000144	0.000283	CcSEcCtD
Succinylcholine—Dermatitis—Epirubicin—hematologic cancer	0.000144	0.000283	CcSEcCtD
Succinylcholine—Rash—Doxorubicin—hematologic cancer	0.000133	0.000262	CcSEcCtD
Succinylcholine—Dermatitis—Doxorubicin—hematologic cancer	0.000133	0.000262	CcSEcCtD
Succinylcholine—CHRM1—Signaling Pathways—STAT5A—hematologic cancer	1.71e-05	0.000109	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—PIK3CB—hematologic cancer	1.7e-05	0.000109	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—STAT5A—hematologic cancer	1.7e-05	0.000109	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—PIK3CB—hematologic cancer	1.7e-05	0.000109	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CDKN2B—hematologic cancer	1.69e-05	0.000108	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—MTHFR—hematologic cancer	1.69e-05	0.000108	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CDKN2B—hematologic cancer	1.69e-05	0.000108	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—STAT5A—hematologic cancer	1.69e-05	0.000108	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—PIK3CB—hematologic cancer	1.68e-05	0.000107	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PIK3R1—hematologic cancer	1.67e-05	0.000107	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CDKN2B—hematologic cancer	1.67e-05	0.000107	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PIK3R1—hematologic cancer	1.67e-05	0.000107	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PIK3R1—hematologic cancer	1.65e-05	0.000106	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CD86—hematologic cancer	1.64e-05	0.000105	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CD86—hematologic cancer	1.63e-05	0.000104	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—JAK2—hematologic cancer	1.63e-05	0.000104	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3CD—hematologic cancer	1.62e-05	0.000104	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—JAK2—hematologic cancer	1.62e-05	0.000104	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CD86—hematologic cancer	1.62e-05	0.000103	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HES1—hematologic cancer	1.61e-05	0.000103	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HES1—hematologic cancer	1.61e-05	0.000103	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—JAK2—hematologic cancer	1.61e-05	0.000103	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NCOR1—hematologic cancer	1.6e-05	0.000103	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—ALB—hematologic cancer	1.6e-05	0.000103	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NCOR1—hematologic cancer	1.6e-05	0.000102	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HES1—hematologic cancer	1.59e-05	0.000102	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—FGF1—hematologic cancer	1.59e-05	0.000102	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CSF2—hematologic cancer	1.59e-05	0.000102	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NCOR1—hematologic cancer	1.58e-05	0.000101	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CSF2—hematologic cancer	1.58e-05	0.000101	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—FGF1—hematologic cancer	1.58e-05	0.000101	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CSF2—hematologic cancer	1.57e-05	0.0001	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—FGF1—hematologic cancer	1.57e-05	0.0001	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—FOXO1—hematologic cancer	1.56e-05	0.0001	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—IL2—hematologic cancer	1.56e-05	0.0001	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PDGFRB—hematologic cancer	1.56e-05	9.99e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—FOXO1—hematologic cancer	1.56e-05	9.97e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—IL2—hematologic cancer	1.56e-05	9.97e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PDGFRB—hematologic cancer	1.56e-05	9.96e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PIK3CB—hematologic cancer	1.55e-05	9.89e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—FOXO1—hematologic cancer	1.54e-05	9.88e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—IL2—hematologic cancer	1.54e-05	9.87e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PDGFRB—hematologic cancer	1.54e-05	9.86e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PIK3CB—hematologic cancer	1.54e-05	9.86e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PDGFRA—hematologic cancer	1.54e-05	9.83e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3R1—hematologic cancer	1.53e-05	9.81e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PDGFRA—hematologic cancer	1.53e-05	9.8e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—JAK1—hematologic cancer	1.53e-05	9.8e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PRKCG—hematologic cancer	1.53e-05	9.8e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—JAK1—hematologic cancer	1.53e-05	9.77e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PRKCG—hematologic cancer	1.53e-05	9.77e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PIK3CB—hematologic cancer	1.53e-05	9.76e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PDGFRA—hematologic cancer	1.52e-05	9.71e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PRKCG—hematologic cancer	1.51e-05	9.67e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—JAK1—hematologic cancer	1.51e-05	9.67e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IL2RA—hematologic cancer	1.43e-05	9.15e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IL2RA—hematologic cancer	1.43e-05	9.12e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CG—hematologic cancer	1.42e-05	9.09e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—IL2—hematologic cancer	1.42e-05	9.08e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3CB—hematologic cancer	1.42e-05	9.06e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—IL2—hematologic cancer	1.42e-05	9.05e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TERT—hematologic cancer	1.41e-05	9.05e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IL2RA—hematologic cancer	1.41e-05	9.03e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TERT—hematologic cancer	1.41e-05	9.02e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—IL2—hematologic cancer	1.4e-05	8.97e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TERT—hematologic cancer	1.4e-05	8.93e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PDGFB—hematologic cancer	1.38e-05	8.83e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PDGFB—hematologic cancer	1.38e-05	8.8e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PDGFB—hematologic cancer	1.36e-05	8.72e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TSC2—hematologic cancer	1.35e-05	8.63e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TSC2—hematologic cancer	1.35e-05	8.6e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TSC2—hematologic cancer	1.33e-05	8.52e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CREBBP—hematologic cancer	1.32e-05	8.43e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—FGFR3—hematologic cancer	1.3e-05	8.3e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—FGFR3—hematologic cancer	1.29e-05	8.28e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MAPK14—hematologic cancer	1.29e-05	8.22e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—FGFR3—hematologic cancer	1.28e-05	8.2e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MAPK14—hematologic cancer	1.28e-05	8.2e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MAPK14—hematologic cancer	1.27e-05	8.12e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ESR1—hematologic cancer	1.26e-05	8.07e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ESR1—hematologic cancer	1.26e-05	8.04e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CD—hematologic cancer	1.25e-05	7.99e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—FN1—hematologic cancer	1.25e-05	7.97e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ESR1—hematologic cancer	1.24e-05	7.96e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—FN1—hematologic cancer	1.24e-05	7.94e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—ALB—hematologic cancer	1.23e-05	7.89e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—BAD—hematologic cancer	1.23e-05	7.87e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NFKBIA—hematologic cancer	1.23e-05	7.87e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—FN1—hematologic cancer	1.23e-05	7.86e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NFKBIA—hematologic cancer	1.23e-05	7.85e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—BAD—hematologic cancer	1.23e-05	7.85e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PTEN—hematologic cancer	1.22e-05	7.83e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NOTCH1—hematologic cancer	1.22e-05	7.8e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NOTCH1—hematologic cancer	1.21e-05	7.77e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NFKBIA—hematologic cancer	1.21e-05	7.77e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—BAD—hematologic cancer	1.21e-05	7.77e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NOTCH1—hematologic cancer	1.2e-05	7.7e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CD80—hematologic cancer	1.19e-05	7.64e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CG—hematologic cancer	1.19e-05	7.62e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—KIT—hematologic cancer	1.19e-05	7.62e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—NRAS—hematologic cancer	1.19e-05	7.62e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CD80—hematologic cancer	1.19e-05	7.61e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CG—hematologic cancer	1.19e-05	7.6e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—KIT—hematologic cancer	1.19e-05	7.6e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—NRAS—hematologic cancer	1.19e-05	7.6e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3R1—hematologic cancer	1.18e-05	7.54e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CD80—hematologic cancer	1.18e-05	7.54e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—KIT—hematologic cancer	1.18e-05	7.53e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CG—hematologic cancer	1.18e-05	7.53e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—NRAS—hematologic cancer	1.18e-05	7.53e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PTPN11—hematologic cancer	1.17e-05	7.49e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PTPN11—hematologic cancer	1.17e-05	7.47e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—EP300—hematologic cancer	1.17e-05	7.46e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PTPN11—hematologic cancer	1.16e-05	7.39e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—MAPK3—hematologic cancer	1.14e-05	7.3e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—MAPK3—hematologic cancer	1.14e-05	7.28e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CREB1—hematologic cancer	1.13e-05	7.26e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CREB1—hematologic cancer	1.13e-05	7.23e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—MAPK3—hematologic cancer	1.13e-05	7.21e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—BRAF—hematologic cancer	1.12e-05	7.17e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CREB1—hematologic cancer	1.12e-05	7.16e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—BRAF—hematologic cancer	1.12e-05	7.14e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCL2—hematologic cancer	1.11e-05	7.1e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IL6R—hematologic cancer	1.11e-05	7.08e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCL2—hematologic cancer	1.11e-05	7.08e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—BRAF—hematologic cancer	1.11e-05	7.07e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CREBBP—hematologic cancer	1.1e-05	7.07e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IL6R—hematologic cancer	1.1e-05	7.06e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CREBBP—hematologic cancer	1.1e-05	7.05e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCL2—hematologic cancer	1.1e-05	7.01e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IL6R—hematologic cancer	1.09e-05	6.99e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CREBBP—hematologic cancer	1.09e-05	6.98e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CB—hematologic cancer	1.09e-05	6.96e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MAP2K1—hematologic cancer	1.05e-05	6.75e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MAP2K1—hematologic cancer	1.05e-05	6.73e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CD—hematologic cancer	1.05e-05	6.7e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CD—hematologic cancer	1.04e-05	6.68e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	1.04e-05	6.66e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	1.04e-05	6.64e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—PIK3CA—hematologic cancer	1.03e-05	6.62e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	1.03e-05	6.62e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—KRAS—hematologic cancer	1.03e-05	6.56e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	1.02e-05	6.55e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—KRAS—hematologic cancer	1.02e-05	6.54e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	1.01e-05	6.48e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—FGF2—hematologic cancer	1e-05	6.42e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—FGF2—hematologic cancer	1e-05	6.4e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—FGF2—hematologic cancer	9.9e-06	6.33e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3R1—hematologic cancer	9.89e-06	6.33e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3R1—hematologic cancer	9.86e-06	6.31e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	9.77e-06	6.25e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—JAK2—hematologic cancer	9.61e-06	6.15e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—JAK2—hematologic cancer	9.58e-06	6.13e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—JAK2—hematologic cancer	9.49e-06	6.07e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PIK3CA—hematologic cancer	9.42e-06	6.03e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PTEN—hematologic cancer	9.41e-06	6.02e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PIK3CA—hematologic cancer	9.39e-06	6.01e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MDM2—hematologic cancer	9.39e-06	6e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MDM2—hematologic cancer	9.36e-06	5.99e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	9.3e-06	5.95e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MDM2—hematologic cancer	9.26e-06	5.93e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MTOR—hematologic cancer	9.13e-06	5.84e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CB—hematologic cancer	9.13e-06	5.84e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MTOR—hematologic cancer	9.1e-06	5.82e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CB—hematologic cancer	9.1e-06	5.82e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MTOR—hematologic cancer	9.01e-06	5.77e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	9.01e-06	5.77e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—EP300—hematologic cancer	8.97e-06	5.74e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—HRAS—hematologic cancer	8.72e-06	5.58e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—HRAS—hematologic cancer	8.69e-06	5.56e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3CA—hematologic cancer	8.63e-06	5.52e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	8.61e-06	5.51e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CDKN1B—hematologic cancer	8.57e-06	5.48e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CDKN1B—hematologic cancer	8.54e-06	5.46e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—AKT1—hematologic cancer	8.48e-06	5.42e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	8.46e-06	5.41e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—AKT1—hematologic cancer	8.45e-06	5.41e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CASP3—hematologic cancer	8.4e-06	5.37e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IL2—hematologic cancer	8.39e-06	5.37e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CASP3—hematologic cancer	8.37e-06	5.36e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	8.37e-06	5.35e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IL2—hematologic cancer	8.36e-06	5.35e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—IL6—hematologic cancer	8.34e-06	5.34e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—IL6—hematologic cancer	8.32e-06	5.32e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CASP3—hematologic cancer	8.29e-06	5.3e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IL2—hematologic cancer	8.28e-06	5.3e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—IL6—hematologic cancer	8.24e-06	5.27e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCND1—hematologic cancer	8.18e-06	5.23e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—JUN—hematologic cancer	8.16e-06	5.22e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCND1—hematologic cancer	8.15e-06	5.21e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—JUN—hematologic cancer	8.13e-06	5.2e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCND1—hematologic cancer	8.07e-06	5.16e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—JUN—hematologic cancer	8.05e-06	5.15e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CDKN1A—hematologic cancer	7.91e-06	5.06e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PTEN—hematologic cancer	7.89e-06	5.05e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CDKN1A—hematologic cancer	7.88e-06	5.04e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PTEN—hematologic cancer	7.87e-06	5.03e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	7.81e-06	4.99e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PTEN—hematologic cancer	7.79e-06	4.98e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MAPK8—hematologic cancer	7.72e-06	4.94e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—AKT1—hematologic cancer	7.7e-06	4.92e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MAPK8—hematologic cancer	7.69e-06	4.92e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—AKT1—hematologic cancer	7.67e-06	4.91e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	7.62e-06	4.87e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	7.6e-06	4.86e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—EP300—hematologic cancer	7.53e-06	4.81e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—EP300—hematologic cancer	7.5e-06	4.8e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—EP300—hematologic cancer	7.43e-06	4.75e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—SRC—hematologic cancer	7.32e-06	4.68e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—SRC—hematologic cancer	7.29e-06	4.67e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—SRC—hematologic cancer	7.22e-06	4.62e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—VEGFA—hematologic cancer	7.13e-06	4.56e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—VEGFA—hematologic cancer	7.1e-06	4.55e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—STAT3—hematologic cancer	7.06e-06	4.51e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—AKT1—hematologic cancer	7.05e-06	4.51e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NRAS—hematologic cancer	7.04e-06	4.5e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	7.04e-06	4.5e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—STAT3—hematologic cancer	7.03e-06	4.5e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NRAS—hematologic cancer	7.02e-06	4.49e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—STAT3—hematologic cancer	6.97e-06	4.46e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NRAS—hematologic cancer	6.95e-06	4.45e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MAPK3—hematologic cancer	6.74e-06	4.31e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MAPK3—hematologic cancer	6.72e-06	4.3e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	6.66e-06	4.26e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CA—hematologic cancer	6.64e-06	4.25e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MYC—hematologic cancer	6.56e-06	4.2e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TGFB1—hematologic cancer	6.54e-06	4.18e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MYC—hematologic cancer	6.54e-06	4.18e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TGFB1—hematologic cancer	6.52e-06	4.17e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MYC—hematologic cancer	6.47e-06	4.14e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	6.46e-06	4.13e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—KRAS—hematologic cancer	6.06e-06	3.88e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—KRAS—hematologic cancer	6.04e-06	3.86e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—KRAS—hematologic cancer	5.98e-06	3.83e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CA—hematologic cancer	5.57e-06	3.56e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CA—hematologic cancer	5.55e-06	3.55e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	5.5e-06	3.52e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—AKT1—hematologic cancer	5.42e-06	3.47e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TP53—hematologic cancer	5.39e-06	3.45e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TP53—hematologic cancer	5.37e-06	3.43e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TP53—hematologic cancer	5.32e-06	3.4e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HRAS—hematologic cancer	5.15e-06	3.29e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HRAS—hematologic cancer	5.13e-06	3.28e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HRAS—hematologic cancer	5.08e-06	3.25e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IL6—hematologic cancer	4.93e-06	3.15e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IL6—hematologic cancer	4.91e-06	3.14e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IL6—hematologic cancer	4.87e-06	3.11e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—AKT1—hematologic cancer	4.55e-06	2.91e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—AKT1—hematologic cancer	4.53e-06	2.9e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—AKT1—hematologic cancer	4.49e-06	2.87e-05	CbGpPWpGaD
